MTOR and neoplasm: Although mTOR inhibitors have originally been used as immune suppressors through the generation of T-regs and reductions in T-cell proliferation, the inhibition of mTOR has both immune suppressive and activatory effects and, under particular conditions and depending upon whether mTORC1 or mTORC2 are inhibited, mTOR inhibition can enhance anti-tumour immune responses [198].